Literature DB >> 24322062

A clinical approach towards smell loss in Parkinson's disease.

Antje Haehner1, Thomas Hummel2, Heinz Reichmann3.   

Abstract

Impairment of olfaction is a characteristic feature of Parkinson's disease (PD). Recent data indicate that >90% of patients with PD are diagnosed with significant olfactory loss. The olfactory loss in PD has a bilateral and general character and all olfactory domains are involved. By clinical measurements, the olfactory deficit in PD is independent of disease severity and duration. Imaging studies however, point out that the olfactory impairment may be progressive in the early motor stages. Deficits in the sense of smell may precede clinical motor symptoms by years and can be used to assess the risk for developing PD in otherwise asymptomatic individuals. Numerous studies suggest that olfactory disturbances in PD may have diagnostic utility for the differentiation of PD from other movement disorders. This review summarizes the available information about the character of olfactory function in PD and possible therapeutic strategies. It indicates the advantageous use of olfactory probes as a contribution to early and differential diagnosis.

Entities:  

Keywords:  Diagnosis; Parkinson's disease; olfaction; parkinsonism; smell

Mesh:

Year:  2014        PMID: 24322062     DOI: 10.3233/JPD-130278

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  17 in total

1.  A prospective evaluation of taste in Parkinson's disease.

Authors:  M J Ricatti; S Ottaviani; F Boschi; A Fasano; M Tinazzi; M P Cecchini
Journal:  J Neural Transm (Vienna)       Date:  2016-11-03       Impact factor: 3.575

2.  Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.

Authors:  Carla Masala; Paolo Solla; A Liscia; G Defazio; L Saba; A Cannas; A Cavazzana; T Hummel; A Haehner
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

3.  [Olfactory function in old age].

Authors:  T Hummel
Journal:  HNO       Date:  2014-09       Impact factor: 1.284

4.  Analysis of the effects of subthalamic nucleus deep brain stimulation on somatosensation in Parkinson's disease patients.

Authors:  Esra Dogru Huzmeli; Atilla Yilmaz; Esra Okuyucu
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

Review 5.  Olfactory dysfunction in dementia.

Authors:  Jorge Alves; Agavni Petrosyan; Rosana Magalhães
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

6.  Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis.

Authors:  L Håglin; I Johansson; L Forsgren; L Bäckman
Journal:  Eur J Clin Nutr       Date:  2016-10-05       Impact factor: 4.016

7.  The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li
Journal:  Exp Neurol       Date:  2019-11-09       Impact factor: 5.330

8.  Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.

Authors:  Iddo Magen; Regina Ostritsky; Franziska Richter; Chunni Zhu; Sheila M Fleming; Vincent Lemesre; Alistair J Stewart; Bruce H Morimoto; Illana Gozes; Marie-Françoise Chesselet
Journal:  Pharmacol Res Perspect       Date:  2014-08-06

9.  A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.

Authors:  Yuji Watanabe; Keisuke Suzuki; Tomoyuki Miyamoto; Masayuki Miyamoto; Ayaka Numao; Hiroaki Fujita; Tomoyuki Uchiyama; Taro Kadowaki; Takeo Matsubara; Koichi Hirata
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

Review 10.  Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Authors:  Rejko Krüger; Jochen Klucken; Daniel Weiss; Lars Tönges; Pierre Kolber; Stefan Unterecker; Michael Lorrain; Horst Baas; Thomas Müller; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2017-03-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.